MedTrace Logo

Antiepileptic Drug Carbamazepine in Treatment of Bronchial Asthma

NCT00207428 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2006-05-16

No results posted yet for this study

Summary

The purpose of this study was evaluation the efficacy of antiepileptic drug carbamazepine in the treatment of mild-to-severe bronchial asthma.

Conditions

  • Bronchial Asthma

Interventions

DRUG

Carbamazepine

Sponsors & Collaborators

  • Rea Rehabilitation Centre, Georgia

    collaborator OTHER

  • Centre of Chinese Medicine, Georgia

    lead OTHER

Principal Investigators

  • Merab Lomia, MD, PhD · "Rea" Rehabilitation Centre

  • Manana Tchaia, MD · Centre of Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-08-31
Completion
2000-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00207428 on ClinicalTrials.gov